AC
CYNA

Aisling Capital’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Aisling Capital’s Portfolio CYNA Stock Details CYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,121,381
Closed -$45.1M – 20
2016
Q3 		$45.1M Buy
1,121,381
+100,000
+10% +$2.47M 9.29% 3
2016
Q2 		$17.1M Hold
1,021,381
– – 4.04% 10
2016
Q1 		$12.2M Hold
1,021,381
– – 2.43% 15
2015
Q4 		$15.6M Buy
1,021,381
+46,190
+5% +$702K 2.69% 14
2015
Q3 		$15.8M Buy
+975,191
New +$15.8M 2.77% 14

Aisling Capital's CYNA Position: Q4 2016 in Review

Aisling Capital sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 1,121,381 shares — an estimated $45.1M sold.

Aisling Capital first reported a position in CYNA in Q3 2015 and held it in 5 quarters. The position peaked at $45.1M in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

  • Aisling Capital reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
  • Aisling Capital sold 1,121,381 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $45.1M.
  • Aisling Capital first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q3 2015 and held it in 5 quarters.
  • Aisling Capital's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $45.1M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on Aisling Capital's 13F filing for Q4 2016, filed 13 Feb 2017.